Huang SM - Search Results

1

Botanical-drug interactions: a scientific perspective.

de Lima Toccafondo Vieira M, Huang SM. de Lima Toccafondo Vieira M, et al. Among authors: huang sm. Planta Med. 2012 Sep;78(13):1400-15. doi: 10.1055/s-0032-1315145. Epub 2012 Aug 3. Planta Med. 2012. PMID: 22864989 Free article. Review.

2

FDA evaluations using in vitro metabolism to predict and interpret in vivo metabolic drug-drug interactions: impact on labeling.

Davit B, Reynolds K, Yuan R, Ajayi F, Conner D, Fadiran E, Gillespie B, Sahajwalla C, Huang SM, Lesko LJ. Davit B, et al. Among authors: huang sm. J Clin Pharmacol. 1999 Sep;39(9):899-910. doi: 10.1177/00912709922008515. J Clin Pharmacol. 1999. PMID: 10471980

3

Drug-drug, drug-dietary supplement, and drug-citrus fruit and other food interactions: what have we learned?

Huang SM, Lesko LJ. Huang SM, et al. J Clin Pharmacol. 2004 Jun;44(6):559-69. doi: 10.1177/0091270004265367. J Clin Pharmacol. 2004. PMID: 15145962 Review.

4

New era in drug interaction evaluation: US Food and Drug Administration update on CYP enzymes, transporters, and the guidance process.

Huang SM, Strong JM, Zhang L, Reynolds KS, Nallani S, Temple R, Abraham S, Habet SA, Baweja RK, Burckart GJ, Chung S, Colangelo P, Frucht D, Green MD, Hepp P, Karnaukhova E, Ko HS, Lee JI, Marroum PJ, Norden JM, Qiu W, Rahman A, Sobel S, Stifano T, Thummel K, Wei XX, Yasuda S, Zheng JH, Zhao H, Lesko LJ. Huang SM, et al. J Clin Pharmacol. 2008 Jun;48(6):662-70. doi: 10.1177/0091270007312153. Epub 2008 Mar 31. J Clin Pharmacol. 2008. PMID: 18378963 Review.

5

Predicting drug-drug interactions: an FDA perspective.

Zhang L, Zhang YD, Zhao P, Huang SM. Zhang L, et al. Among authors: huang sm. AAPS J. 2009 Jun;11(2):300-6. doi: 10.1208/s12248-009-9106-3. Epub 2009 May 6. AAPS J. 2009. PMID: 19418230 Free PMC article. Review.

6

Scientific and regulatory perspectives on metabolizing enzyme-transporter interplay and its role in drug interactions: challenges in predicting drug interactions.

Zhang L, Zhang Y, Huang SM. Zhang L, et al. Among authors: huang sm. Mol Pharm. 2009 Nov-Dec;6(6):1766-74. doi: 10.1021/mp900132e. Mol Pharm. 2009. PMID: 19839641 Review.

7

Drug interactions evaluation: an integrated part of risk assessment of therapeutics.

Zhang L, Reynolds KS, Zhao P, Huang SM. Zhang L, et al. Among authors: huang sm. Toxicol Appl Pharmacol. 2010 Mar 1;243(2):134-45. doi: 10.1016/j.taap.2009.12.016. Epub 2010 Jan 4. Toxicol Appl Pharmacol. 2010. PMID: 20045016 Review.

8

CYP-mediated therapeutic protein-drug interactions: clinical findings, proposed mechanisms and regulatory implications.

Lee JI, Zhang L, Men AY, Kenna LA, Huang SM. Lee JI, et al. Among authors: huang sm. Clin Pharmacokinet. 2010 May;49(5):295-310. doi: 10.2165/11319980-000000000-00000. Clin Pharmacokinet. 2010. PMID: 20384392 Review.

9

Clinical pharmacology as a cornerstone of orphan drug development.

Bashaw ED, Huang SM, Coté TR, Pariser AR, Garnett CE, Burckart G, Zhang L, Men AY, Le CD, Charlab R, Gobburu JV, Lesko LJ. Bashaw ED, et al. Among authors: huang sm. Nat Rev Drug Discov. 2011 Oct 31;10(11):795-6. doi: 10.1038/nrd3595. Nat Rev Drug Discov. 2011. PMID: 22037026

10

The utility of modeling and simulation in drug development and regulatory review.

Huang SM, Abernethy DR, Wang Y, Zhao P, Zineh I. Huang SM, et al. J Pharm Sci. 2013 Sep;102(9):2912-23. doi: 10.1002/jps.23570. Epub 2013 May 24. J Pharm Sci. 2013. PMID: 23712632 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

1,230 results

Search Page